ABBOTT LABORATORIES
For the period ended Sep 30, 2024. Filed Oct 31, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Oct 31, 2024
ABT$109.93-3.2%Stored close · as of Nov 6, 2026
Contents
Table of Contents
Abbott Laboratories
| Part I - Financial Information | |
|---|---|
| Page | |
| Item 1. Financial Statements and Supplementary Data | |
| Condensed Consolidated Statement of Earnings | 3 |
| Condensed Consolidated Statement of Comprehensive Income | 4 |
| Condensed Consolidated Balance Sheet | 5 |
| Condensed Consolidated Statement of Shareholders’ Investment | 6 |
| Condensed Consolidated Statement of Cash Flows | 8 |
| Notes to the Condensed Consolidated Financial Statements | 9 |
| Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations | 25 |
| Item 4. Controls and Procedures | 32 |
| Part II - Other Information | 32 |
| Item 1. Legal Proceedings | 32 |
| Item 2. Unregistered Sales of Equity Securities and Use of Proceeds | 33 |
| Item 6. Exhibits | 34 |
| Signature | 35 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.